Aberrant newborn T cell and microbiota developmental trajectories predict respiratory compromise during infancy
A. Grier, N. Laniewski, A. L. Gill, H. A. Kessler, H. Huyck, J. Holden-Wiltse, S. Bandyopadhyay, J. Carnahan, A. M. Dylag, D. J. Topham, A. R. Falsey, M. T. Caserta, G. S. Pryhuber, S. R. Gill, A. McDavid, K. M. Scheible
The paper identifies that prenatal antibiotics or infection disrupt T cell and microbiota development, increasing respiratory morbidity risk in infants.
bioRxiv · Jun 16, 2020 · PreprintImmunology